Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 2Sanofi
02 4Dr. Reddy's Laboratories
03 1Polfa Tarchomin
04 2NanoAlvand
05 4Supriya Lifescience
06 2Naprod Life Sciences
07 1Ever Pharma
08 8Accord Healthcare Pty. Ltd.
09 10Accord healthcare
10 2Accure Labs
11 2Actavis Inc
12 1Adamed Pharma
13 2Apotex Inc
14 1Aurobindo Pharma Limited
15 2BAXTER HEALTHCARE PTY LTD
16 1Baxter Healthcare Corporation
17 1Biem Ilac San. ve Tic. A.S
18 1Centocor
19 1CinnaGen Co
20 1Cipla Medpro South Africa
21 1Curanto Pharma
22 1DR REDDY'S LABORATORIES LTD
23 1Dr Reddy's Laboratories (Pty) Ltd
24 2EUGIA PHARMA (AUSTRALIA) PTY LTD
25 1Eurolab Pty Ltd
26 2Flagship Biotech International Pvt. Ltd
27 2Fresenius Kabi USA
28 2GetWell Pharmaceutical
29 1Glenmark Pharmaceuticals
30 1HETERO LABS LTD VI
31 1Hansoh Pharma
32 1Hetero Drugs
33 3Hospira, Inc.
34 4InterPharma
35 1JUNO PHARMACEUTICALS CORP.
36 6Janssen-Cilag
37 2Jodas Expoim Pvt. Ltd
38 2Johnson & Johnson Innovative Medicine
39 4Juno Pharmaceuticals Pty Ltd
40 1MARCAN PHARMACEUTICALS INC
41 1MSN Laboratories
42 2Maia Pharmaceuticals
43 1Meitheal Pharmaceuticals
44 1NORVIUM BIOSCIENCE
45 1Nishchay Pharmaceuticals Pvt. Ltd.
46 1Panacea Biotec Limited
47 8Pfizer Consumer Healthcare
48 1Pfizer Inc
49 2Pharmacore Inc
50 2Pharmascience Inc.
51 1Qilu Pharmaceutical
52 1RANBAXY LABORATORIES LIMITED
53 1RELIANCE LIFE SCI
54 1SEACROSS PHARMACEUTICALS
55 1Sakar Healthcare
56 2Samyang Biopharmaceuticals
57 7Sandoz B2B
58 1ScinoPharm Taiwan, Ltd
59 1Shilpa Medicare
60 2Spirig Healthcare
61 1Takeda Pharmaceutical
62 2Taro Pharmaceutical Industries
63 2Tecnimede
64 4Teva Pharmaceutical Industries
65 2TherDose Pharma
66 1Vinkem Labs Ltd
67 1Zydus Pharmaceuticals
01 1Bortezomid 3,5Mg 1 Unit Parenteral Use
02 8Dry Sub
03 1FREEZE-DRIED POWDER
04 9INJ
05 2INJECTABLE; INJECTION
06 20INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
07 2INJECTION
08 3Inj L?s
09 1Inj Solution
10 1Injectable
11 10Injection
12 1LYOPHILIZED INJECTION
13 2Lyo.Inj
14 2Lyophilised Injection
15 3Lyophilized Injection
16 1Lyophilized Powder for IV/SC Injectable Solution
17 4Lyophilized Powder for Injection
18 2POI
19 12POWDER FOR SOLUTION
20 2POWDER FOR SOLUTION FOR INJECTION
21 2POWDER;INTRAVENOUS
22 2POWDER;INTRAVENOUS, SUBCUTANEOUS
23 2PULVER TILL INJEKTIONSVÄTSKA, LÖSNING
24 2Powder for Injectable Solution
25 1Powder for Solution for Injection
26 1Powder for injection fluid, resolution
27 4SOLUTION;INTRAVENOUS
28 1SOLUTION;INTRAVENOUS, SUBCUTANEOUS
29 1Solution for Injection
30 2Vial
31 1inj
32 33Blank
01 10DISCN
02 1Dossier Available
03 19Generic
04 1Lead Market Dossiers- Approved in both US & EU
05 1Lead Market Dossiers- Filed
06 2Originator
07 19RX
08 86Blank
01 1ACT BORTEZOMIB
02 3Alvocade
03 31BORTEZOMIB
04 2BORTEZOMIB EUGIA
05 5BORTEZOMIB FOR INJECTION
06 1BORTEZOMIB FOR INJECTION SDZ
07 2BOTETHER
08 1BOTIGEN 3,5
09 1Bertred 3,5
10 1Biemib
11 2Bortezom
12 10Bortezomib Accord
13 2Bortezomib Accord liquid
14 2Bortezomib Baxter
15 4Bortezomib Ever Pharma
16 4Bortezomib Juno
17 4Bortezomib Sandoz
18 2Bortezomib Zentiva
19 2Bortezomib liquid Spirig HC
20 1Bortiv
21 1Bortrac 3,5 mg
22 8DBL Bortezomib
23 1Miblex
24 2NEOMIB
25 1Norzib 2
26 1Onbort
27 1PMS-BORTEZOMIB
28 2PROTEZOMIB
29 2TARO-BORTEZOMIB
30 1VALOMA 3,5
31 4VELCADE
32 1VELZOMY
33 1Valtib
34 1Valtib 1,0 mg
35 5Velcade
36 1Velcade 1 mg
37 1bortezomib Accord
38 1bortezomib Sandoz
39 23Blank
01 32Australia
02 1Austria
03 12Canada
04 22India
05 3Iran
06 1Italy
07 1Norway
08 2Poland
09 2Portugal
10 12South Africa
11 2South Korea
12 4Sweden
13 12Switzerland
14 1Turkey
15 31USA
16 1United Kingdom
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Bortezomib Zentiva
Dosage Form : Dry Sub
Dosage Strength : 1mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-07-26
Application Number : 202963
Regulatory Info : RX
Registration Country : USA
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Powder for Solution for Injection
Dosage Strength : 3.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Alvocade
Dosage Form : Vial
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilized Powder for Injection
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 2MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info :
Registration Country : Austria
Brand Name :
Dosage Form : Solution for Injection
Dosage Strength : 2.5MG/1ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Austria
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Bortezomib Zentiva
Dosage Form : Dry Sub
Dosage Strength : 3.5mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2019-10-04
Application Number : 206927
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in both US & EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in both US & EU
Registration Country : India
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Alvocade
Dosage Form : Vial
Dosage Strength : 3.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilized Powder for Injection
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilized Powder for Injection
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilized Powder for Injection
Dosage Strength : 3.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 3.5MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-07-26
Application Number : 204405
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date :
Application Number : 208645
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 3.5MG/1.4ML
Packaging :
Approval Date :
Application Number : 208645
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-05-02
Application Number : 205533
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2017-11-06
Application Number : 205004
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-07-26
Application Number : 208460
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 1MG/VIAL
Packaging :
Approval Date : 2022-05-02
Application Number : 209191
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 2.5MG/VIAL
Packaging :
Approval Date : 2022-05-02
Application Number : 209191
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-07-26
Application Number : 209622
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-05-02
Application Number : 208392
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-07-26
Application Number : 203654
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VELCADE
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2003-05-13
Application Number : 21602
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-05-02
Application Number : 205857
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-10-31
Application Number : 205160
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
